Biological functions of angiotensin and its receptors

Annual Review of Physiology

Volumn 59, Issue , 1997, Pages 395-412

  Matsusaka, T ^a   Ichikawa, I ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

aldosterone; extracellular matrix; heart failure; JG cells; renal failure

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ENALAPRIL; HYDRALAZINE;

GENETIC POLYMORPHISM; HORMONAL REGULATION; HUMAN; HUMAN CELL; ION TRANSPORT; KIDNEY CELL; KIDNEY DEVELOPMENT; KIDNEY DISEASE; ONTOGENY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR DENSITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANIMALS; EXTRACELLULAR MATRIX; HEART; HUMANS; JUXTAGLOMERULAR APPARATUS; KIDNEY; KIDNEY DISEASES; RECEPTORS, ANGIOTENSIN;

EID: 0030948534     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.59.1.395     Document Type: Review

References (100)

1. Aguilera G. 1993. Factors controlling steroid biosynthesis in the zona glomerulosa of the adrenal. J. Steroid Biochem. Mol. Biol. 45:147-51
2. Aguilera G, Catt KJ. 1978. Regulation of aldosterone secretion by the renin-angiotensin system during sodium restriction in rats. Proc. Natl. Acad. Sci. USA 75:4057-61
3. Aguilera G, Hauger RL, Catt KJ. 1978. Control of aldosterone secretion during sodium restriction: adrenal receptor regulation and increased adrenal sensitivity to angiolensin II. Proc. Natl. Acad. Sci. USA 75:975-79
4. Allan DR, McKnight JA, Kifor I, Coletti CM, Hollenberg NK. 1994. Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24:516-22
5. Antonaccio MJ, Rubin B, Horovitz ZP, Laffan RJ, Goldberg ME, et al. 1979. Effect of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme in spontaneously hypertensive rats. Jpn. Pharmacol. 29:285-94
6. Baricos WH, Cortez SL, el-Dahr SS, Schnaper HW. 1995. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int. 47:1039-47
7. Beaufils M, Sraer J, Lepreux C, Ardaillou R. 1976. Angiotensin II binding to renal glomeruli from sodium-loaded and sodium-depleted rats. Am. J. Physiol. 230:1187-93
8. Bellucci A, Wilkes BM. 1984. Mechanism of sodium modulation of glomerular angiotensin receptors in the rat. J. Clin. Invest. 74:1593-600
9. Blair-West JR, Cain MD, Catt KJ, Coghlan JP, Denton DA, et al. 1971. The dissociation of aldosterone secretion and systemic renin and angiotensin II levels during the correction of sodium deficiency. Acta Endocrinol. 66:229-47
10. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. 1993. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin. Genet. 44:298-301
11. Boyd JE, Palmore WP, Mulrow PJ. 1971. Role of potassium in the control of aldosterone secretion in the rat. Endocrinology 88:556-65
12. Bradshaw B, Moore TJ. 1988. Abnormal regulation of adrenal angiotensin II receptors in spontaneously hypertensive rats. Hypertension 11:49-54
13. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, et al. 1992. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-44
14. Cattran DC, Greenwood C, Ritchie S. 1994. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am. J. Kidney Dis. 23:247-54
15. Challah M, Nicoletti A, Arnal JF, Philippe M, Laboulandine I, et al. 1995. Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension. Cardiovasc. Res. 30:231-39
16. Chang RS, Lotti VJ. 1990. Two distinct angiotensin II receptor binding sites in rat adrenal revealed new by selective nonpeptide ligands. Mol. Pharmacol. 37:347-51
17. Chansel D, Bizet T, Vandermeersch S, Pham P, Levy B, Ardaillou R. 1994. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells. Am. J. Physiol. 266:F384-93
18. Cheng HF, Becker BN, Burns KD, Harris RC. 1995. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J. Clin. Invest. 95:2012-19
19. Correa FM, Viswanathan M, Ciuffo GM, Tsutsumi K, Saavedra JM. 1995. Kidney angiotensin II receptors and converting enzyme in neonatal and adult Wistar-Kyoto and spontaneously hypertensive rats. Peptides 16:19-24
20. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. 1993. Angiotensin I converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem J. 290:33-40
21. Crawford DC, Chobanian AV, Brecher P 1994. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ. Res. 74:727-39
22. Della Bruna R, Ries S, Himmelstoss C, Kurtz A. 1995. Expression of cardiac angiotensin II AT1 receptor genes in rat hearts is regulated by steroids but not by angiotensin II. J. Hyperlens. 13:763-69
23. Doi Y, Atarashi K, Franco-Saenz R, Mulrow PJ. 1984. Effect of changes in sodium or potassium balance, and nephrectomy on adrenal renin and aldosterone concentrations. Hypertension 6:1124-29
24. Dostal DE, Baker KM. 1992. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor. Am. J. Hypertens. 5:276-80
25. Dzau VJ, Re R. 1994. Tissue angiotensin system in cardiovascular medicine: a paradigm shift? Circulation 89:493-98
26. Feener EP, Northup JM, Aiello LP, King GL. 1995. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J. Clin. Invest. 95:1353-62
27. Fukushima T, Nomura S, Kawai S, Osawa G. 1995. ACE genotype and progression of IgA nephropathy. Lancet 346:571
28. Gasc JM, Shanmugam S, Sibony M, Corvol P. 1994. Tissue-specific expression of type I angiotensin II receptor subtypes. An in situ hybridization study. Hypertension 24:531-37
29. Gupta P, Franco-Saenz R, Mulrow PJ. 1995. Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin-, and potassium-stimulated aldosterone secretion. Hypertension 25: 443-48
30. Haefliger JA, Bergonzelli G, Waeber G, Aubert JF, Nussberger J, et al. 1995. Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats. Hypertension 26:733-37
31. Harden PN, Geddes C, Boulton Jones M, Briggs JD, Junor JR, et al. 1994. Polymorphism in the ACE gene in patients with renal disease. J. Am. Soc. Nephrol. 5:330 (Abstr.)
32. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton Jones M, et al. 1995. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345:1540-42
33. Holland OB, Carr BC, Braisier AR. 1995. Aldosterone synthase gene regulation by angiotensin. Endocr. Res. 21:455-62
34. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, et al. 1991. Effect on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748-50
35. Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I. 1991. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int. 40:195-202
36. Inagami T, Iwai N, Sasaki K, Guo DF, Furuta H, et al. 1993. Angiotensin II receptors: cloning and regulation. Arzneim. Forsch. 43:226-28
37. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, et al. 1995. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl. Acad. Sci. USA 92:3521-25
38. Iwai N, Inagami T. 1992. Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem. Biophys. Res. Commun. 182:1094-99
39. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, et al. 1992. Molecular basis of human hypertension: role of angiotensinogen. Cell 71:169-80
40. Johns DW, Peach MJ, Gomez RA, Inagami T, Carey RM. 1990. Angiotensin II regulates renin gene expression. Am. J. Physiol. 259:F882-87
41. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, et al. 1992. Renal injury from angiotensin II mediated hypertension. J. Hypertens. 19:464-74
42. Kagami S, Border WA, Miller DE, Noble NA. 1994. Angiotensin II stimulates matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest. 93:2431-37
43. Kakinuma Y, Fogo A, Inagami T, Ichikawa I. 1993. Intrarenal localization of angiotensin II type 1 receptor mRNA in the rat. Kidney Int. 43:1229-35
44. Kakuchi J, Ichiki T, Kiyama S, Hogan BLM, Fogo A, et al. 1995. Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int. 47:140-47
45. Kaneto H, Morrissey J, Klahr S. 1993. Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int. 44:313-21
46. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, et al. 1994. Contribution of renal angiotensin II type 1 receptor to gene expressions in hypertension-induced renal injury. Kidney Int. 46:1346-58
47. Kitami Y, Okura T, Marumoto K, Wakamiya R, Hiwada K. 1992. Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem. Biophys. Res. Commun. 188:446-52
48. Lee LK, Meyer TW, Pollock AS, Lovett DH. 1995. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J. Clin. Invest. 96:953-64
49. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. 1993. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329:1456-62
50. Lindpaintner K, Lee M, Larson MG, Rao S, Pfeffer MA, et al. 1996. Absence of association or genetic linkage between the angiotensin converting-enzyme gene and left ventricular mass. N. Engl. J. Med. 334:1023-28
51. Linz W, Scholkens BA, Ganten D. 1989. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin. Exp. Hypertens. A11:1325-50
52. Llorens-Cortes C, Greenberg B, Huang H, Corvol P. 1994. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24:538-48
53. Lopez JJ, Lorell BH, Ingelfinger JR, Weinberg EO, Schunkert H, et al. 1994. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am. J. Physiol. 267:H844-52
54. Lorenz JN, Weihprecht H, He X, Skøtt O, Briggs JP, Schnermann J. 1993. Effect of adenosine and angiotensin on macula densa-stimulated renin secretion. Am. J. Physiol. 265:F187-94
55. Makita N, Iwai N, Inagami T, Badr K. 1992. Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cells. Biochem. Biophys. Res. Commun. 185:142-46
56. Matsusaka T, Nishimura H, Utsunomiya H, Kakuchi J, Niimura F, et al. 1996. Chimeric mice carrying regional targeted deletion of the angiotensin type 1A receptor gene: evidence against the role for local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells. J. Clin. Invest. In press
57. Meggs LG, Coupet J, Huang H, Cheng W, Li P, et al. 1993. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ. Res. 72:1149-62
58. Mendelsohn FAO, Dunbar M, Allen A, Chou ST, Millan MA, et al. 1986. Angiotensin II receptors in the kidney. Fed. Proc. 45:1420-25
59. Michel JB, Lattion AL, Salzmann JL, de Lourdes Cerol M, Philippe M, et al. 1988. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ. Res. 62:641-50
60. Mitani F, Suzuki H, Hata J, Ogishima T, Shimada H, Ishimura Y. 1994. A novel cell layer without corticosteroid-synthesizing enzymes in rat adrenal cortex: histochemical detection and possible physiological role. Endocrinology 135:431-38
61. Modrall JG, Quinones MJ, Frankhouse JH, Hsueh WA, Weaver FA, Kedes L. 1995. Upregulation of angiotensin II type 1 receptor gene expression in chronic renovascular hypertension. J. Surg. Res. 59:135-40
62. Naftilan AJ, Oparil S. 1978. Inhibition of renin release from rat kidney slices by the angiotensins. Am. J. Physiol. 235:F62-68
63. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, et al. 1995. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. USA 92:10663-67
64. Nakamaru M, Misono KS, Naruse M, Workman RJ, Inagami T. 1985. A role for the adrenal renin-angiotensin system in the regulation of potassium-stimulated aldosterone production. Endocrinology 117:1772-78
65. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, et al. 1995. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J. Clin. Invest. 96:2947-54
66. Norwood VF, Garmey M, Gomez RA. 1995. Type 2 angiotensin receptor (AT-2) inhibits in vitro glomerulogenesis. J. Am. Soc. Nephrol. 6:704 (Abstr.)
67. Palmore WP, Marieb NJ, Mulrow PJ. 1969. Stimulation of aldosterone secretion by sodium depletion in nephrectomized rats. Endocrinology 84:1342-51
68. Penhoat A, Jaillard C, Crozat A, Saez J. 1988. Regulation of angiotensin II receptors and steroidogenic responsiveness in cultured bovine fasciculata and glomerulosa adrenal cells. Eur. J. Biochem. 172:247-54
69. Pfeffer JM, Fischer TA, Pfeffer MA. 1995. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu. Rev. Physiol. 57:805-26
70. Pimentel JL, Montero A, Wang S, Yosipiv I, El-Dahr S, Martinez-Maldonado M. 1995. Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. Kidney Int. 48:1247-53
71. Platia MP, Catt KJ, Hodgen GD, Aguilera G. 1986. Regulation of primate angiotensin II receptors during altered sodium intake. Hypertension 8:1121-26
72. Pratt RE, Bradshaw B, Moore TJ, Dzau VJ. 1988. Altered expression of the adrenal renin-angiotensin system in spontaneously hypertensive rats (SHR). Circulation 78:II59 (Abstr.)
73. Ray PE, Bruggerman LA, Horikoshi S, Aguilera G, Klotman PE. 1994. Angiotensin II stimulates human fetal mesan-gial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int. 45:177-84
74. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, et al. 1993. Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 342:1073-75
75. Regitz-Zagrosek V, Auch-Schwelk W, Neuss M, Fleck E. 1994. Regulation of the angiotensin receptor subtypes in cell culture, animal models and human diseases. Eur. Heart J. 15:92-97 (Suppl. D)
76. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Wiliams GH, Vaughan DE. 1993. Stimulation of plasminogen activator inhibitor (PAI-1) in vivo by infusion of angiotension II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 7:1969-73
77. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1343-46
78. Sadoshima J, Izumo S. 1993. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ. Res. 73:413-23
79. Sadoshima J, Xu Y, Slayter, HS, Izumo S. 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75:977-84
80. Skorecki KL, Ballerman BJ, Rennke HG, Brenner BM. 1983. Angiotensin II receptor regulation in isolated renal glomeruli. Fed Proc. 42:3064-70
81. Song K, Kurobe Y, Kanehara H, Okunishi H, Wada T, et al. 1994. Quantitative localization of angiotensin II receptor subtypes in spontaneously hypertensive rats. Blood Press 5:21-26 (Suppl.)
82. Song K, Zhuo J, Allen AM, Paxinos G, Mendelsohn FAO. 1991. Angiotensin II receptor subtypes in rat brain and peripheral tissues. Cardiology 79:45-54 (Suppl. 1)
83. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber KT. 1994. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc. Res. 28:1423-32
84. Suzuki J, Matsubara H, Urakami M, Inada M. 1993. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ. Res. 73:439-47
85. Tian Y, Balla T, Baukal AJ, Catt KJ. 1995. Growth responses to angiotensin II in bovine adrenal glomerulosa cells. Am. J. Physiol. 268:E135-44
86. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, et al. 1994. Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344:910-12
87. Tremblay A, Lehoux JG. 1992. Influence of captopril on adrenal cytochrome P-450s and adrenodoxin expression in high potassium or low sodium intake. J. Steroid Biochem. Mol. Biol. 41:799-808
88. Tufro-McReddie A, Gomez RA, Norling LL, Omar AA, Moore LC, Kaskel FJ. 1993. Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney. Kidney Int. 43:615-22
89. Tufro-McReddie A, Johns DW, Geary KM, Dagli H, Everett AD, et al. 1994. Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. Am. J. Physiol. 266:F911-18
90. Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomes RA. 1995. Angiotensin II regulates nephrogenesis and renal vascular development. Am. J. Physiol. 269:F110-15
91. Ullian ME, Schelling RJ, Linas SL. 1992. Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses. Hypertension 20:67-73
92. van Essen GG, Rensma PL, Apperloo AJ, Scheffer H, Sluiter WJ, et al. 1995. ACE-gene polymorphism predicts rate of loss of renal function in non-diabetic chronic renal failure. J. Am. Soc. Nephrol. 6:407 (Abstr.)
93. von Lutterotti N, Catanzaro DF, Sealey JE, Laragh JH. 1994. Renin is not synthesized by cardiac and extrarenal vascular tissues: a review of experimental evidence. Circulation 89:493-98
94. Weber KT, Brilla CG. 1993. Structural basis for pathologic left ventricular hypertrophy. Clin. Cardiol. 16:11-10-14
95. Wolf G, Mueller E, Stahl RA, Ziyadeh FN. 1993. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J. Clin. Invest. 92:1366-72
96. Wright RA, Flapan AD, Alberti KG, Ludlam CA, Fox KA. 1994. Effects of captopril therapy on endogenous fibrinolysis in men with recent uncomplicated myocardial infarction. J. Am. Coll. Cardiol. 24:67-73
97. Yoshida H, Kakuchi J, Guo D, Furuta H, Iwai N, et al. 1992. Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human). Biochem. Biophys. Res. Commun. 186:1042-49
98. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, et al. 1996. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int. 50:657-64
99. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, et al. 1995. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest. 96:2162-69
100. Zhuo J, Alcorn D, McCausland J, Mendelsohn FAO. 1994. Localization and regulation of angiotensin II receptors in renomedullary interstitial cells. Kidney Int. 46:1483-85